![](/img/cover-not-exists.png)
135P A multicenter retrospective observation study about overall survival benefit of eribulin mesylate in comparison with taxane regimens for metastatic cancer patients
Kikuchi, Y., Uchida, Y., Kanauchi, H., Niwa, T., Nishioka, K., Tada, K., Hashimoto, M., Yasuda, H., Kawabata, H., Seto, Y., Ogawa, T.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw577.018
Date:
December, 2016
File:
PDF, 73 KB
2016